Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Volke V, Katus U, Johannson A, et al.
BMC Endocr Disord. 2022;22(1):251.
Leggi
Volke V, Katus U, Johannson A, et al.
BMC Endocr Disord. 2022;22(1):251.
Leggi
Ke C, Lipscombe LL, Weisman A, et al.
JAMA. Pub. online 14 Oct 2022.
Leggi
Lin T, Manfredo JA, Illesca N, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2022.
Leggi
Boje AS, Sørensen MH, Gæde P, Madsen PL
Diabetes Care. 2022;dc220942.
Leggi
Mutie PM, Pomares-Milan H, Atabaki-Pasdar N, et al.
Diabetologia. Pub. online 12 Oct 2022.
Leggi
Rifai MA, Szklo M, Patel J, et al.
Am J Cardiol. 2022;S0002-9149(22)00958-4.
Leggi
Forst T, Mathieu C, Giorgino F, et al.
BMC Med. 2022;20(1):337.
Leggi
Nejatian MM, Lan NSR, Yeap BB, et al.
Diabetes Res Clin Pract. 2022;192:110093.
Leggi
Ørskov M, Vorum H , Bjerregaard Larsen T, et al.
Am J Med. 2022;S0002-9343(22)00723-9.
Leggi
Faggiano A, Mazzilli R, Natalicchio A, Adinolfi V, Argentiero A, Danesi R, D’Oronzo S, Fogli S, Gallo M, Giuffrida D, Gori S, Montagnani M, Ragni A, Renzelli V, Russo A, Silvestris N, Franchina T, Tuveri E, Cinieri S, Colao A, Giorgino F, Zatelli MC
Crit Rev Oncol Hematol. 2022;180:103826.
Leggi